Crossmark

Evaluation of plan robustness on the dosimetry of volumetric arc radiotherapy (VMAT) with set-up uncertainty in Nasopharyngeal carcinoma (NPC) radiotherapy

Crossref DOI link: https://doi.org/10.1186/s13014-021-01970-8

Published Online: 2022-01-03

Published Print: 2022-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ding, Zhen https://orcid.org/0000-0001-6002-8863
Xiang, Xiaoyong

Zeng, Qi

Ma, Jun

Dai, Zhitao

Kang, Kailian

Bi, Suyan
Funding

Funding for this research was provided by:

Sanming Project of Medicine in Shenzhen (SZSM201612063)

National Key Clinical Specialty Discipline Construction Program of China (SZXK013)
License Information

Text and Data Mining valid from 2022-01-03

Version of Record valid from 2022-01-03
More Information

Article History

Received: 30 August 2021

Accepted: 17 December 2021

First Online: 3 January 2022

Declarations

:

: The study was approved by the institutional review board of National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital. We confirm that all methods were carried out in accordance with relevant guidelines and regulations.

: The patients gave their informed consent for use of the data for research purposes.

: The authors state that they have no competing interests.

Document is current

Any future updates will be listed below